ReviewInternational journal of molecular sciences2026
Impact of Obstructive Sleep Apnea on Blood-Brain Barrier Permeability and Membrane Proteins.
Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The blood-brain barrier (BBB) carefully regulates the transport of molecules between the blood and the nervous tissue. Obstructive sleep apnea (OSA) is a chronic condition that induces structural and functional changes in the BBB. These include alterations in its permeability and in protein expression in the BBB capillary endothelium. Moreover, OSA alters blood levels of transcription factors, such as hypoxia-inducible factor 1 (HIF-1), which are suggested to be responsible for these changes. As a review article, this paper focuses on the most significant effects of OSA on the BBB, including deviations in barrier morphology, particularly changes in the expression of tight junction and adherens junction proteins and membrane channels, as well as their impact on transport across the barrier. Moreover, particular attention is given to emerging evidence for the differential regulation of major BBB efflux transporters, including P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP), as well as the role of the HIF-1 pathway. Additionally, we summarize the current state of knowledge regarding the contribution of these BBB alterations to the development of neurodegenerative diseases. At the same time, altered transport is being investigated as a possibility for delivering new drugs to the central nervous system. Thus, this review aims to summarize the current knowledge about OSA's impact on the BBB.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.